Using Modifiable Risk Factors to Predict Inferior Care and Survival after Breast Cancer Diagnosis: A Novel Approach to Addressing Health Disparities

使用可改变的风险因素来预测乳腺癌诊断后的不良护理和生存:解决健康差异的新方法

基本信息

  • 批准号:
    10681334
  • 负责人:
  • 金额:
    $ 19.44万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-08-06 至 2024-08-31
  • 项目状态:
    已结题

项目摘要

RESEARCH SUMMARY / ABSTRACT Despite overall declines in breast cancer mortality in the United States, significant disparities in breast cancer treatment and outcomes persist. Access-related, biological, psychosocial, and provider-specific factors previously demonstrated to be associated with disparities after breast cancer diagnosis are, on the whole, static systemic or individual features that are difficult or impossible to change. As an alternative approach to addressing disparities in breast cancer, we propose creating a risk prediction model for Breast cancer Risk of Inferior Survival and Care (BRISC) that incorporates dynamic, modifiable risk factors to identify women at greatest risk for compromised care and worse survival after diagnosis with breast cancer. After development and validation, we will use the BRISC model to conduct statistical simulations and costing activities to estimate the improvement in value (i.e., outcomes achieved per health-care dollar spent) achieved via implementation of high-impact, risk-modifying interventions to facilitate receipt of guideline-concordant breast cancer treatment. Finally, we will develop a parsimonious, clinic-based data collection tool to be completed by patients and providers for the purpose of operationalizing the BRISC model as a component of routine oncologic care.
研究摘要/摘要

项目成果

期刊论文数量(18)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Breast cancer among African American and sub-Saharan African women: a tale of global inequities.
非裔美国人和撒哈拉以南非洲妇女的乳腺癌:全球不平等的故事。
  • DOI:
    10.1007/s10552-022-01641-3
  • 发表时间:
    2022-12
  • 期刊:
  • 影响因子:
    2.3
  • 作者:
    Gutnik, Lily;Olopade, Olufunmilayo, I;Newman, Lisa A.;Fayanju, Oluwadamilola M.
  • 通讯作者:
    Fayanju, Oluwadamilola M.
Trends in Racial, Ethnic, and Sex Representation Among Surgical Faculty Members and Medical Students in the US, 2011-2020.
2011-2020 年美国外科教员和医学生的种族、民族和性别代表趋势。
  • DOI:
    10.1001/jamasurg.2021.4904
  • 发表时间:
    2021
  • 期刊:
  • 影响因子:
    16.9
  • 作者:
    Yu,AliceYunziL;Iwai,Yoshiko;Thomas,SamanthaM;Beasley,GeorgiaM;Sudan,Ranjan;Fayanju,OluwadamilolaM
  • 通讯作者:
    Fayanju,OluwadamilolaM
Disparities in Breast-Conserving Therapy Versus Mastectomy Among Asian American and Pacific Islander Women.
亚裔美国和太平洋岛民女性保乳治疗与乳房切除术的差异。
  • DOI:
    10.1245/s10434-023-13315-8
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Patel,TejA;Dee,EdwardChristopher;Jain,Bhav;Vapiwala,Neha;Santos,PatriciaMaeG;Fayanju,OluwadamilolaM
  • 通讯作者:
    Fayanju,OluwadamilolaM
Controversies in Breast Cancer Surgery.
Optimizing Sentinel Node Biopsy After Neoadjuvant Therapy: Striving to Know What We Do Not Know.
新辅助治疗后优化前哨淋巴结活检:努力了解我们不知道的事情。
  • DOI:
    10.1245/s10434-022-12942-x
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    3.7
  • 作者:
    Woodward,StevenG;Fayanju,OluwadamilolaM
  • 通讯作者:
    Fayanju,OluwadamilolaM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Oluwadamilola M. Fayanju其他文献

ASO Visual Abstract: Living Flat–Stories from Women of Color After Mastectomy
  • DOI:
    10.1245/s10434-024-16395-2
  • 发表时间:
    2024-11-12
  • 期刊:
  • 影响因子:
    3.500
  • 作者:
    Jasmine A. Khubchandani;Sakinah C. Suttiratana;Rosetta Washington;Dawn White-Bracey;Madhav KC;Andrea Silber;Oluwadamilola M. Fayanju;Paris D. Butler;Alka Menon;Rachel A. Greenup
  • 通讯作者:
    Rachel A. Greenup
ASO Visual Abstract: Survival Outcomes Among Patients with Metastatic Breast Cancer: Review of 47,000 Patients
  • DOI:
    10.1245/s10434-021-10296-4
  • 发表时间:
    2021-07-13
  • 期刊:
  • 影响因子:
    3.500
  • 作者:
    Mahsa Taskindoust;Samantha M. Thomas;Sarah Sammons;Oluwadamilola M. Fayanju;Gayle DiLalla;E. Shelley Hwang;Jennifer K. Plichta
  • 通讯作者:
    Jennifer K. Plichta
ASO Author Reflections: Metaplastic Breast Cancer—The Case for Doing Less and More
  • DOI:
    10.1245/s10434-018-7009-1
  • 发表时间:
    2018-11-09
  • 期刊:
  • 影响因子:
    3.500
  • 作者:
    Oluwadamilola M. Fayanju
  • 通讯作者:
    Oluwadamilola M. Fayanju
Medicaid Expansion and Clinical Trials-Why Doing the Right Thing Helps Us Do the Best Science.
医疗补助扩展和临床试验 - 为什么做正确的事可以帮助我们做出最好的科学研究。
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    28.4
  • 作者:
    S. Obeng;Oluwadamilola M. Fayanju
  • 通讯作者:
    Oluwadamilola M. Fayanju
ASO Visual Abstract: Landmark Series—Addressing Disparities in Breast Cancer Screening: New Recommendations for Black Women
  • DOI:
    10.1245/s10434-022-12665-z
  • 发表时间:
    2022-10-30
  • 期刊:
  • 影响因子:
    3.500
  • 作者:
    Oluwadamilola M. Fayanju;Christine E. Edmonds;Sylvia A. Reyes;Cletus Arciero;Vivian J. Bea;Angelena Crown;Kathie-Ann Joseph
  • 通讯作者:
    Kathie-Ann Joseph

Oluwadamilola M. Fayanju的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Oluwadamilola M. Fayanju', 18)}}的其他基金

Using Modifiable Risk Factors to Predict Inferior Care and Survival after Breast Cancer Diagnosis: A Novel Approach to Addressing Health Disparities
使用可改变的风险因素来预测乳腺癌诊断后的不良护理和生存:解决健康差异的新方法
  • 批准号:
    10462957
  • 财政年份:
    2021
  • 资助金额:
    $ 19.44万
  • 项目类别:
Using Modifiable Risk Factors to Predict Inferior Care and Survival after Breast Cancer Diagnosis: A Novel Approach to Addressing Health Disparities
使用可改变的风险因素来预测乳腺癌诊断后的不良护理和生存:解决健康差异的新方法
  • 批准号:
    9805887
  • 财政年份:
    2019
  • 资助金额:
    $ 19.44万
  • 项目类别:

相似海外基金

I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 19.44万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了